Autolus Therapeutics (AUTL) Treasury Shares (2017 - 2025)
Historic Treasury Shares for Autolus Therapeutics (AUTL) over the last 4 years, with Q3 2025 value amounting to $94375.0.
- Autolus Therapeutics' Treasury Shares rose 16080.53% to $94375.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $94375.0, marking a year-over-year increase of 16080.53%. This contributed to the annual value of $32412.0 for FY2024, which is 7216.32% down from last year.
- Per Autolus Therapeutics' latest filing, its Treasury Shares stood at $94375.0 for Q3 2025, which was up 16080.53% from $16250.0 recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Treasury Shares ranged from a high of $403331.0 in Q4 2022 and a low of $16250.0 during Q1 2025
- Over the past 4 years, Autolus Therapeutics' median Treasury Shares value was $41905.0 (recorded in 2024), while the average stood at $89207.1.
- Per our database at Business Quant, Autolus Therapeutics' Treasury Shares tumbled by 7216.32% in 2024 and then surged by 16080.53% in 2025.
- Quarter analysis of 4 years shows Autolus Therapeutics' Treasury Shares stood at $403331.0 in 2022, then tumbled by 71.13% to $116436.0 in 2023, then tumbled by 72.16% to $32412.0 in 2024, then surged by 191.17% to $94375.0 in 2025.
- Its Treasury Shares stands at $94375.0 for Q3 2025, versus $16250.0 for Q2 2025 and $16250.0 for Q1 2025.